- Page 1 and 2:
CMS Manual System Pub. 100-07 State
- Page 3 and 4:
State Operations Manual Appendix PP
- Page 5 and 6:
§483.25(n) Influenza and Pneumococ
- Page 7 and 8:
(including eligibility, coverage, c
- Page 9 and 10:
___________________________________
- Page 11 and 12:
Procedures §483.10(a)(3) and (4) D
- Page 13 and 14:
―Advance directive‖ means a wri
- Page 15 and 16:
§483.10(b)(5) -- The facility must
- Page 17 and 18:
Provide written information concern
- Page 19 and 20:
___________________________________
- Page 21 and 22:
§483.10(c)(3) Deposit of Funds (i)
- Page 23 and 24:
Were limits placed on amounts that
- Page 25 and 26:
___________________________________
- Page 27 and 28:
(B) Dietary services as required at
- Page 29 and 30:
medical service that is recognized
- Page 31 and 32:
satisfactorily resolved by discussi
- Page 33 and 34:
(i) Transfer to another health care
- Page 35 and 36:
Interpretive Guidelines §483.10(g)
- Page 37 and 38:
(ii) Any representative of the Stat
- Page 39 and 40:
___________________________________
- Page 41 and 42:
efore the resident may exercise tha
- Page 43 and 44:
§483.12(a) Transfer, and Discharge
- Page 45 and 46:
§483.10(o), Tag F177, addresses th
- Page 47 and 48:
Look for changes in source of payme
- Page 49 and 50:
How to notify the ombudsman (name,
- Page 51 and 52:
___________________________________
- Page 53 and 54:
Interpretive Guidelines §483.12(d)
- Page 55 and 56:
Interpretive Guidelines §483.12(d)
- Page 57 and 58:
―Convenience‖ is defined as any
- Page 59 and 60:
order reflecting the presence of a
- Page 61 and 62:
consistently implemented. Determine
- Page 63 and 64:
monitored separation from other Res
- Page 65 and 66:
to prevent occurrences, monitoring
- Page 67 and 68:
injurious behaviors, residents with
- Page 69 and 70:
A certified nurse aide found guilty
- Page 71 and 72:
o Day-to-day use of plastic cutlery
- Page 73 and 74:
for the resident‘s safety. For ex
- Page 75 and 76:
If a facility changes its policy to
- Page 77 and 78:
___________________________________
- Page 79 and 80:
Staff should strive to reasonably a
- Page 81 and 82:
egarding medical information. The f
- Page 83 and 84:
The report stated that, ―Resident
- Page 85 and 86:
If not contraindicated, modifying t
- Page 87 and 88:
o Visual interaction and to compens
- Page 89 and 90:
For residents from diverse ethnic o
- Page 91 and 92:
Encouraging volunteer-type work tha
- Page 93 and 94:
12 Christenson, M.A. (1996). Enviro
- Page 95 and 96:
selected this activity. The Nationa
- Page 97 and 98:
Interview the social services staff
- Page 99 and 100:
Identifies how the facility will pr
- Page 101 and 102:
o Determine if the facility has acc
- Page 103 and 104:
(ii) Has 2 years of experience in a
- Page 105 and 106:
Once the team has completed its inv
- Page 107 and 108:
___________________________________
- Page 109 and 110:
transportation services that are no
- Page 111 and 112:
F252 (Rev. 66, Issued: 10-01-10, Ef
- Page 113 and 114:
Although this Tag can be used for i
- Page 115 and 116:
___________________________________
- Page 117 and 118:
___________________________________
- Page 119 and 120:
Intent §483.20 To provide the faci
- Page 121 and 122:
(vii) Psychosocial well-being ―Ps
- Page 123 and 124:
___________________________________
- Page 125 and 126:
Resident‘s decision making change
- Page 127 and 128:
___________________________________
- Page 129 and 130:
(i) Admission assessment. (ii) Annu
- Page 131 and 132:
Completing an assessment that is no
- Page 133 and 134:
Interpretive Guidelines §483.20(h)
- Page 135 and 136:
Submitting correction(s) to informa
- Page 137 and 138:
If the resident has refused treatme
- Page 139 and 140:
. Do the dietitian and speech thera
- Page 141 and 142:
Are physicians‘ orders carried ou
- Page 143 and 144:
What types of pre-discharge prepara
- Page 145 and 146:
If the resident‘s PAS report indi
- Page 147 and 148:
Briefly review the assessment, care
- Page 149 and 150:
and knowledge of the resident, shou
- Page 151 and 152:
Determine whether the facility had
- Page 153 and 154:
NOTE: Guidance regarding pressure u
- Page 155 and 156:
The resident has the right to refus
- Page 157 and 158:
others being hypersensitivity, idio
- Page 159 and 160:
Examples of clinical resources avai
- Page 161 and 162:
indicators which may represent pain
- Page 163 and 164:
• Impact of pain on quality of li
- Page 165 and 166:
National Center for Complementary a
- Page 167 and 168:
3 National Center for Complementary
- Page 169 and 170:
The objective of this protocol is t
- Page 171 and 172:
How effective the interventions hav
- Page 173 and 174:
Nurse Interview. Interview a nurse
- Page 175 and 176:
Communicated with the health care p
- Page 177 and 178:
qualified persons with input from t
- Page 179 and 180:
of pain. First, the team must rule
- Page 181 and 182:
The resident experienced daily or l
- Page 183 and 184:
Extensive Assistance - While reside
- Page 185 and 186:
Procedures: §483.25(a)(1)(ii) Dete
- Page 187 and 188:
Identify if resident triggers CAAs
- Page 189 and 190:
USE OF SPEECH, LANGUAGE, OR OTHER F
- Page 191 and 192:
___________________________________
- Page 193 and 194:
Probes: §483.25(b) Identify if res
- Page 195 and 196:
―Debridement‖- Debridement is t
- Page 197 and 198:
OVERVIEW A pressure ulcer can occur
- Page 199 and 200:
procedures, during prolonged ambula
- Page 201 and 202:
Assessment of a resident‘s skin c
- Page 203 and 204:
Both urine and feces contain substa
- Page 205 and 206:
use of lifting devices for repositi
- Page 207 and 208:
in accord with resident‘s overall
- Page 209 and 210:
Whether pain, if present, is being
- Page 211 and 212:
Some clinicians utilize validated i
- Page 213 and 214:
generally impairs wound healing, se
- Page 215 and 216:
15 Fuhrer M., Garber S., Rintola D.
- Page 217 and 218:
of Localized Chronic Wound Infectio
- Page 219 and 220:
Previously unidentified open areas;
- Page 221 and 222:
complications including reassessmen
- Page 223 and 224:
If not, the development of the pres
- Page 225 and 226:
o Determine if the care plan was pe
- Page 227 and 228:
Examples of possible avoidable nega
- Page 229 and 230:
(Rev. 66, Issued: 10-01-10, Effecti
- Page 231 and 232:
later stages of dementia, diabetes,
- Page 233 and 234:
the resident‘s concerns and offer
- Page 235 and 236:
Functional and cognitive capabiliti
- Page 237 and 238:
toileting and response to specific
- Page 239 and 240:
cognitive deficit—provided that t
- Page 241 and 242:
the epidermis (comparable to a deep
- Page 243 and 244:
adequate. Based on the resident‘s
- Page 245 and 246:
Follow-Up of UTIs rectal temperatur
- Page 247 and 248:
9 Maki, D.G. & Tambyah, P.A. (2001)
- Page 249 and 250:
Whether the resident is on a schedu
- Page 251 and 252:
catheter/continence services. Reque
- Page 253 and 254:
Defines the catheter, tubing and ba
- Page 255 and 256:
If the attending physician is unava
- Page 257 and 258:
Assess, prevent (to the extent poss
- Page 259 and 260:
perform relevant activities of dail
- Page 261 and 262:
Requires immediate correction, as t
- Page 263 and 264:
The failures of the facility to pro
- Page 265 and 266:
Identify if resident triggers CAAs
- Page 267 and 268:
Probes: §483.25(f)(1) For sampled
- Page 269 and 270:
___________________________________
- Page 271 and 272:
Using universal precautions and cle
- Page 273 and 274:
Monitor the effectiveness of the
- Page 275 and 276:
Directs resources to address safety
- Page 277 and 278:
Monitoring is the process of evalua
- Page 279 and 280:
those (e.g., disease, environment)
- Page 281 and 282:
Addressing the factors for the fall
- Page 283 and 284:
155°F 148°F 140°F 133°F 127°F
- Page 285 and 286:
NOTE: The Safe Medical Devices Act
- Page 287 and 288:
ENDNOTES 1 Centers for Medicare & M
- Page 289 and 290:
Use To evaluate whether the facilit
- Page 291 and 292:
2. Interview The adequacy of the su
- Page 293 and 294:
Changes in condition such as the ab
- Page 295 and 296:
Noncompliance for F323 After comple
- Page 297 and 298:
Once the survey team has completed
- Page 299 and 300:
Unsafe wandering and/or elopement t
- Page 301 and 302:
Severity Level 1 Considerations: No
- Page 303 and 304:
―Qualified dietitian‖ refers to
- Page 305 and 306:
Current standards of practice recom
- Page 307 and 308:
dry mouth, and diseases of the orop
- Page 309 and 310:
Based on analysis of relevant infor
- Page 311 and 312:
For many residents (including overw
- Page 313 and 314:
In deciding whether and how to inte
- Page 315 and 316:
End-of-Life Resident choices and cl
- Page 317 and 318:
11 Chouinard, J. (2000). Dysphagia
- Page 319 and 320:
Objectives Use INVESTIGATIVE PROTOC
- Page 321 and 322:
Nutrition interventions, such as sn
- Page 323 and 324:
Whether the facility identified res
- Page 325 and 326:
Review of Facility Practices Relate
- Page 327 and 328:
42 CFR §483.20(b)(1), Tag F272, Co
- Page 329 and 330:
DEFICIENCY CATEGORIZATION (Part IV,
- Page 331 and 332:
If immediate jeopardy has been rule
- Page 333 and 334:
Intent §483.25(j) The intent of th
- Page 335 and 336:
Is proper administration technique
- Page 337 and 338:
§483.25(k)(5) Standard: Tracheal S
- Page 339 and 340:
(v) In the presence of adverse cons
- Page 341 and 342:
physical actions such as: pacing, c
- Page 343 and 344:
o Support decisions about modifying
- Page 345 and 346:
individual with dementia, to improv
- Page 347 and 348:
Medication management is based in t
- Page 349 and 350:
Whether the signs, symptoms, or rel
- Page 351 and 352:
o Pain; o Chronic psychiatric illne
- Page 353 and 354:
Common Conditions/ Symptoms Example
- Page 355 and 356:
Identifying the essential informati
- Page 357 and 358:
necessarily indicate a need for dos
- Page 359 and 360:
Sometimes, the decision about wheth
- Page 361 and 362:
The continued use is in accordance
- Page 363 and 364:
J., & Bates, D.W. (2005). Incidence
- Page 365 and 366:
(NSAIDs) Medication Issues and Conc
- Page 367 and 368:
Antibiotics Medication Issues and C
- Page 369 and 370:
Medication Issues and Concerns prim
- Page 371 and 372:
Medication Issues and Concerns Mono
- Page 373 and 374:
chlorpropamide glyburide Antifungal
- Page 375 and 376:
Medication Issues and Concerns MAO
- Page 377 and 378:
Medication Issues and Concerns days
- Page 379 and 380:
Medication Issues and Concerns Medi
- Page 381 and 382:
uspirone Medication Issues and Conc
- Page 383 and 384:
Medication Issues and Concerns amio
- Page 385 and 386:
Medication Issues and Concerns Angi
- Page 387 and 388:
Nitrates, e.g., Medication Issues a
- Page 389 and 390:
Medication Issues and Concerns Anti
- Page 391 and 392:
Medication Issues and Concerns esom
- Page 393 and 394:
Medication Issues and Concerns laxa
- Page 395 and 396:
Medication Issues and Concerns Resp
- Page 397 and 398:
Medication Issues and Concerns hygi
- Page 399 and 400:
Medication Issues and Concerns All
- Page 401 and 402:
iperiden trihexyphenidyl olanzapine
- Page 403 and 404:
NOTE: This review is not intended t
- Page 405 and 406:
If during the review, you identify
- Page 407 and 408:
How he/she approaches the MRR proce
- Page 409 and 410:
o Failure to monitor a medication c
- Page 411 and 412:
42 CFR 483.20(b), F272, Comprehensi
- Page 413 and 414:
Complications (such as diarrhea wit
- Page 415 and 416:
NOTE: If Severity Level 3 (actual h
- Page 417 and 418:
―Resident Condition‖ -- The res
- Page 419 and 420:
Medication Errors Due to Failure to
- Page 421 and 422:
Medications Administered with Enter
- Page 423 and 424:
if the facility uses the ―recap
- Page 425 and 426:
technique requires a comparison of
- Page 427 and 428:
eaction to the vaccine than would h
- Page 429 and 430:
o Persons who are 50 years of age o
- Page 431 and 432:
Sampling: To determine if education
- Page 433 and 434:
Processes to address issues that ar
- Page 435 and 436:
The facility failed to document tha
- Page 437 and 438:
Requires immediate correction as th
- Page 439 and 440:
(ii) other nursing personnel. §483
- Page 441 and 442:
(3) The State finds that, for any p
- Page 443 and 444:
(A) Has only patients whose physici
- Page 445 and 446:
For SNFs and SNF/NFs which may be w
- Page 447 and 448:
Assessing special nutritional needs
- Page 449 and 450:
Probes: §483.35(c)(1) Are resident
- Page 451 and 452:
___________________________________
- Page 453 and 454:
Interpretive Guidelines: §483.35(f
- Page 455 and 456:
―Food Preparation‖ refers to th
- Page 457 and 458:
for growth of harmful pathogens. Ba
- Page 459 and 460:
Source of Primary Agents of Primary
- Page 461 and 462:
Food Receiving and Storage When foo
- Page 463 and 464:
specified below will either kill da
- Page 465 and 466:
may consist of a combination of foo
- Page 467 and 468:
at the manifold, which is the area
- Page 469 and 470:
INVESTIGATIVE PROTOCOL SANITARY CON
- Page 471 and 472:
2. Interview Observe that foods are
- Page 473 and 474:
cooling, and ensure that PHF/TCS fo
- Page 475 and 476:
2. Degree of harm (actual or potent
- Page 477 and 478:
Severity Level 1 Considerations: No
- Page 479 and 480:
Intent: §483.35(h) The intent of t
- Page 481 and 482:
Whether they are assisting assigned
- Page 483 and 484:
and drink. If concerns are identifi
- Page 485 and 486:
Compliance with 42 CFR 483.35(h), F
- Page 487 and 488:
eligibility to eat and drink with a
- Page 489 and 490:
Examples of the facility‘s non-co
- Page 491 and 492:
delegating and supervising follow-u
- Page 493 and 494:
Probes: §483.40(b) Do services ord
- Page 495 and 496:
For what reasons are residents sent
- Page 497 and 498:
(2) Obtain the required services fr
- Page 499 and 500:
Probes: §483.45(a)(1)(2) 1. For ph
- Page 501 and 502:
a care plan must be developed, foll
- Page 503 and 504:
Are residents missing teeth and may
- Page 505 and 506:
Definitions are provided to clarify
- Page 507 and 508:
The National Coordinating Council f
- Page 509 and 510:
Establish procedures that address m
- Page 511 and 512:
How the receipt of medications from
- Page 513 and 514:
Documentation of actual disposition
- Page 515 and 516:
the pharmaceutical services. Fourth
- Page 517 and 518:
The facility‘s failure to involve
- Page 519 and 520:
The facility in collaboration with
- Page 521 and 522:
(2) The pharmacist must report any
- Page 523 and 524:
errors, or other irregularities, an
- Page 525 and 526:
NOTE: The surveyor‘s review of me
- Page 527 and 528:
o Seizure activity; o Spontaneous o
- Page 529 and 530:
Common Medication-Medication Intera
- Page 531 and 532:
The identification of any irregular
- Page 533 and 534:
aspects of pharmaceutical services.
- Page 535 and 536:
The pharmacist‘s MRR failed to id
- Page 537 and 538:
(3) Determines that drug records ar
- Page 539 and 540:
During a medication pass, medicatio
- Page 541 and 542:
This requirement has several aspect
- Page 543 and 544:
Determine whether the noncompliance
- Page 545 and 546:
§483.65 Infection Control The faci
- Page 547 and 548: ―Contact precautions‖ are measu
- Page 549 and 550: Critical aspects of the infection p
- Page 551 and 552: Conducting data analysis to help de
- Page 553 and 554: observations of staff practices and
- Page 555 and 556: Complications from invasive diagnos
- Page 557 and 558: Airborne transmission can occur by
- Page 559 and 560: After removing gloves or aprons; an
- Page 561 and 562: Depending on the situation, options
- Page 563 and 564: tears or holes be replaced. It is r
- Page 565 and 566: ENDNOTES 68 Siegel, J.D., Rhinehart
- Page 567 and 568: Guidelines for environmental infect
- Page 570 and 571: INVESTIGATIVE PROTOCOL FOR INFECTIO
- Page 572 and 573: Multiple use items (e.g., shower ch
- Page 574 and 575: Interview the Designated Infection
- Page 576 and 577: Utilize infection precautions to mi
- Page 578 and 579: Properly implement transmission bas
- Page 580 and 581: influenza in residents on another,
- Page 582 and 583: §483.70(a)(6)(ii) The dispensers a
- Page 584 and 585: Additional guidance is available in
- Page 586 and 587: §483.70(d)(1)(i) Accommodate no mo
- Page 588 and 589: Procedures: §483.70(d)(1)(iv) Ther
- Page 590 and 591: Interpretive Guidelines: §483.70(d
- Page 592 and 593: centralized nursing station, this c
- Page 594 and 595: Are spaces adaptable for all intend
- Page 596 and 597: defined as substandard quality of c
- Page 600 and 601: Probes: §483.75(e)(2 - 4) During a
- Page 602 and 603: 1919(e)(2)(A) of the Act the facili
- Page 604 and 605: Interpretive Guidelines: §483.75(f
- Page 606 and 607: The medical director helps the faci
- Page 608 and 609: MEDICAL DIRECTION The facility is r
- Page 610 and 611: The medical director is responsible
- Page 612 and 613: REFERENCES 1 Pattee JJ, Otteson OJ.
- Page 614 and 615: support with ventilators, intraveno
- Page 616 and 617: The medical director provides input
- Page 618 and 619: V. DEFICIENCY CATEGORIZATION (Part
- Page 620 and 621: NOTE: If immediate jeopardy has bee
- Page 622 and 623: Intent: §483.75(j)(1) The intent o
- Page 624 and 625: Probes: §483.75(j)(1)(i) - (iv) Ar
- Page 626 and 627: An inability to order radiological
- Page 628 and 629: There is a written policy, at the h
- Page 630 and 631: If there is a problem with confiden
- Page 632 and 633: (i) Residents will be transferred f
- Page 634 and 635: Preventing deviation from care proc
- Page 636 and 637: Meetings of the QAA committee must
- Page 638 and 639: INVESTIGATIVE PROTOCOL QUALITY ASSE
- Page 640 and 641: The assigned surveyor should interv
- Page 642 and 643: 2. Degree of harm (actual or potent
- Page 644 and 645: The facility‘s QAA committee meet
- Page 646 and 647: R04SOM 11/12/2004 Guidance to Surve
- Page 648 and 649:
e. Special Care Fl19____ Receiving
- Page 650 and 651:
Form CMS-672 (10/10) ReSIDent CenSu
- Page 652 and 653:
Form CMS-672 (10/10) ReSIDent CenSu
- Page 654 and 655:
DEPARTMENT OF HEALTH AND HUMAN SERV
- Page 656 and 657:
22. Psychoactive Medications: If th
- Page 658 and 659:
16. Weight Change/Nutrition/Swallow
- Page 660 and 661:
RESIDENT REVIEW WORKSHEET (continue
- Page 662:
RESIDENT REVIEW WORKSHEET (continue